Celecoxib inhibits prostate cancer growth: Evidence of a cyclooxygenase-2-independent mechanism Academic Article uri icon

Overview

MeSH Major

  • Cyclooxygenase Inhibitors
  • Lactones
  • Prostatic Neoplasms
  • Pyrazoles
  • Sulfonamides
  • Sulfones

abstract

  • Two clinically available selective COX-2 inhibitors possess different COX-2-independent anticancer properties. The anticancer activity of celecoxib may reflect COX-2-independent in addition to COX-2-dependent effects.

publication date

  • March 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-04-1877

PubMed ID

  • 15756026

Additional Document Info

start page

  • 1999

end page

  • 2007

volume

  • 11

number

  • 5